Literature DB >> 8398517

New patch delivery system for percutaneous local anaesthesia.

D F McCafferty1, A D Woolfson.   

Abstract

We have assessed the release of amethocaine from a new patch delivery system and subsequent drug diffusion through human stratum corneum and whole skin. We found that the patch system was more efficient than an amethocaine gel preparation. It was also observed, both in vitro and in vivo, that the stratum corneum acted as a reservoir for amethocaine. A double-blinded clinical trial, using 30- and 60-min application times, indicated that there was no statistical difference between patch and gel formulations in onset of percutaneous local anaesthesia. Furthermore, a 30-min application of the patch was sufficient to provide profound and prolonged topical anaesthesia in all volunteers. In contrast, although a 60-min application of EMLA was necessary to ensure satisfactory onset of percutaneous anaesthesia, the duration of action was much shorter than that of the amethocaine patch.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8398517     DOI: 10.1093/bja/71.3.370

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  4 in total

1.  Topical use of local anesthetics in neonates.

Authors:  C M Essink-Tjebbes; Y A Hekster; K D Liem; R T van Dongen
Journal:  Pharm World Sci       Date:  1999-08

2.  A physiological pharmacokinetic model for solute disposition in tissues below a topical below a topical application site.

Authors:  M S Roberts; S E Cross
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

3.  A pilot study on the use of a plasma skin regeneration device (Portrait PSR3) in full facial rejuvenation procedures.

Authors:  Suzanne Kilmer; Natalie Semchyshyn; Geeta Shah; Richard Fitzpatrick
Journal:  Lasers Med Sci       Date:  2007-03-07       Impact factor: 3.161

4.  Percutaneous dermal drug delivery for local pain control.

Authors:  Sujatha Tadicherla; Brian Berman
Journal:  Ther Clin Risk Manag       Date:  2006-03       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.